Skip to content


  • Oral presentation
  • Open Access

Quantitative study of gait and balance in normal pressure hydrocephalus

  • 1Email author,
  • 2,
  • 1,
  • 1,
  • 2 and
  • 1
Cerebrospinal Fluid Research20096 (Suppl 1) :S39

  • Published:


  • Stride Length
  • Postural Instability
  • Normal Pressure Hydrocephalus
  • Normal Pressure Hydrocephalus
  • Lumbar Drainage


While gait impairment and postural instability are often observed in Normal Pressure Hydrocephalus (NPH), the severity and pattern of these deficits at presentation and after treatment are uncertain. To date, qualitative clinical assessment of gait and posture has been, in large part, standard of care in the diagnosis and treatment of NPH. Recent advances in biomechanical technology are now available that can provide quantitative measures to supplement and/or extend standard clinical assessment and to further distinguish NPH from other co-morbidities. In this investigation, we demonstrate the usefulness of four newly-developed biomechanical apparati (Cranial Accelerometer, Force Plate, Kinematic Gait and Dynamic Treadmill) to quantify gait impairment and postural instability in patients being diagnosed and surgically treated for NPH.

Materials and methods

This is a prospective clinical outcome study of sixty-two patients screened for the diagnosis of NPH through 36-hour, CSF trial drainage to determine their candidacy for CSF shunt treatment which, in part, employs standard gait assessment (time*steps/m). In addition to our standard screening for functional improvement, each subject was evaluated on Cranial Accelerometer, Force Plate, Kinematic Gait and Dynamic Treadmill, before and after 36-hour, continuous trial CSF lumbar drainage (CCF-NPH Protocol) and after 3 months. Data was analyzed at presentation and after drainage, and compared between responders and non-responders.


Overall, in sixty-two patients (32 M/30 F) ranging in age from 47–94 y.o. (mean 72.6) we obtained quantitative measures in each of the four biometric tests at presentation and after extended CSF drainage. Mainly, we observed quantitative gait and postural changes after CSF trial drainage. Specifically, Cranial Accelerometer data showed significant changes in head movement (H1, H2, and CTI) corresponding to "A-P sway" which were greatly exaggerated during eyes-closed task. Using the Force Plate, we found significant changes in postural movement in both the X and Y planes, and Total Path Length (TPL) during eyes-open and eyes-closed tasks, which correlated with Cranial Accelerometer results in responders and non-responders. Kinematic Gait showed improvement (~10–20%) in speed, stride length, step width, and turning speed which responders were significantly better than non-responders after CSF drainage. Dynamic Treadmill data revealed significant differences between responders and non-responders in symmetry for left/right vertical forces and medial-lateral forces after CSF drainage. In responders, improvement in gait and posture observed with trial CSF drainage was often, but not always retained at 3 M post-shunt treatment; by comparison, non-responders performance showed no change or deterioration at 3 M follow up. Several quantitative gait and postural measures significantly correlated with standard gait assessment.


This study provides accurate and reliable quantitative data that reflects the gait and postural impairment observed clinically in patients with NPH. Importantly, we were able to confirm and extend gait and postural improvement in patients undergoing CSF trial drainage using the Cranial Accelerometer, Force Plate, Kinematic Gait and Dynamic Treadmill testing which is currently being assessed clinically. At this time, quantitative gait and postural evaluation may not supplant but assist in clinical diagnosis and treatment of NPH.



Support for this investigation provided by Medtronic, Inc. and Codman & Shurtleff, Inc., a Johnson & Johnson Co.

Authors’ Affiliations

Department of Neurosurgery, Section of Pediatric and Congenital Neurosurgery, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Department of Biomedical Engineering, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA


© Dombrowski et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.